Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 281.00
+3.00 (1.08%)
Dec 5, 2025, 1:30 PM CST
Alar Pharmaceuticals Revenue
Alar Pharmaceuticals had revenue of 1.25M TWD in the twelve months ending September 30, 2025, down -99.74% year-over-year. In the year 2024, Alar Pharmaceuticals had annual revenue of 5.82M, down -98.76%.
Revenue (ttm)
1.25M
Revenue Growth
-99.74%
P/S Ratio
14,980.69
Revenue / Employee
46.41K
Employees
27
Market Cap
18.77B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 34.99M |
| PharmaEssentia | 13.82B |
| Lotus Pharmaceutical | 18.66B |
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 42.59M |
| Center Laboratories | 1.57B |
| Pegavision | 6.90B |